New Delhi: India’s first Covid – 19 Intranasal vaccine, iNCOVACC was launched by Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh today. The vaccine has been developed by India’s Bharat Biotech, the vaccine will be available to the government for ₹ 325 per dose, while it will cost ₹ 800 to private hospitals.
Vaccine will be administered in 2 doses in a span of 28 days.
The Central Drugs Standard Control Organisation (CDSCO) had approved the restricted use of the intranasal vaccine in emergency situations in the age group of 18 and above.
The nasal vaccine cannot be administered to those who have taken a precaution or booster dose. As per the vaccine maker Bharat Biotech, one can book an appointment for the intranasal vaccine dose by visiting the CoWin website.
iNCOVACC was developed in partnership with the Washington University, St. Louis, which had designed and developed the recombinant adenoviral vectored construct and evaluated in preclinical studies for efficacy.
#India #First Covid – 19 #Intranasal vaccine #iNCOVACC #launched #Union Health Minister #Dr Mansukh Mandaviya #Science and Technology Minister #Jitendra Singh #Vaccine #India’s Bharat Biotech #Government #Dose #Private hospitals